Rheumatoid arthritis: when the inflammation is controlled but the pain is not.

Your bloodwork says the disease is quiet. Your joints say otherwise. Both can be true, and the nervous system is often the missing piece.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What rheumatoid arthritis is

Rheumatoid arthritis, usually shortened to RA, is an autoimmune disorder. The immune system, which should defend the body, mistakenly attacks the synovium, the thin lining inside the joints. The lining swells, the joint becomes warm, stiff and painful, and over years the inflammation can wear away cartilage and bone and change the shape of the joint. RA tends to affect the same joints on both sides of the body, often starting in the hands, wrists and feet, and it commonly brings morning stiffness lasting more than an hour, fatigue and a general sense of being unwell. In severe cases it can affect the lungs, heart, eyes and blood vessels.

RA is diagnosed with a combination of examination, blood tests (rheumatoid factor, anti-CCP antibodies, inflammation markers such as CRP and ESR) and imaging. It is treated with disease-modifying drugs, biologics and sometimes steroids, and modern treatment can bring the disease into remission for many people.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms generated by learned pathways in the brain and nervous system rather than by ongoing damage or disease in the body. Pain is an alarm the brain produces to protect you. Years of genuine inflammatory pain are, in effect, years of training that alarm to fire easily. The alarm can stay loud, or get louder, even when the inflammation that started it has been brought under control. This is not imaginary and it is not 'all in your head'. And because the brain is plastic, the alarm can be retrained.

The ATNS Index of Neuroplastic Symptoms takes a careful position on RA. It says, in plain terms, that RA is not caused by neuroplastic symptoms. But it also says that in some people with RA, neuroplastic symptoms contribute to what they feel, and that this is particularly likely when the course of the condition over time, or the response to treatment, is not typical. The index adds a hopeful detail: a study found that, in addition to medication, journaling about emotions helped reduce RA pain.

In practice, the neuroplastic contribution tends to show up as:

• Pain that does not track with inflammation markers, swelling or imaging.
• Pain that spreads beyond the inflamed joints to muscles, the back or the whole body, a pattern that overlaps with fibromyalgia.

Our guide to central sensitization explains the mechanism in more depth.

What the research shows

This is one of the better-studied examples of a structural disease with a nervous-system overlay. A 2026 review of shared mechanisms across fibromyalgia, osteoarthritis and inflammatory arthritis concluded that central sensitization, an increased responsiveness of central pain pathways, contributes to persistent pain in RA that may not correlate with inflammation or structural damage. It describes the signature features: heightened pain response, pain from normally harmless touch, pain spreading beyond the original site, and weakened natural pain inhibition.

A hospital-based study of people with RA found that a substantial share showed features of central sensitization even without a fibromyalgia diagnosis, and that both central sensitization and neuropathic-type pain were linked to higher pain scores and higher measured disease activity. The authors describe a mixed 'top-down and bottom-up' pain profile: inflammation from the joints and amplification from the nervous system at the same time.

A systematic review across RA, psoriatic arthritis and spondyloarthritis pooled 47 primary studies and found that sensitization features were associated with higher symptom-weighted disease activity scores, more patient-reported symptom burden, worse function, poorer sleep, mood symptoms and lower quality of life. Importantly, the symptom-based disease activity scores can be inflated by sensitization, which can make RA look more active than it is and lead to escalating medication that does not help the pain.

Signs the brain may be part of the picture

• Your rheumatologist says the disease is in remission or low activity, but your pain has not improved, or has grown.
• You are tender to light pressure in many places, not just swollen joints.
• Stress, worry or sadness reliably bring on a flare, and calm periods reliably ease it.

A solution that addresses it

There is an approach built for the nervous-system part of pain, and it sits alongside RA treatment rather than replacing it. Pain and symptom reprocessing combines education about neuroplastic pain, somatic tracking (observing the sensation with curiosity instead of alarm), lowering fear and the sense of threat, a graded return to activity, emotional awareness and expression, and acceptance and commitment skills. The emotional-expression element matches what the ATNS index highlights for RA. Trained clinicians deliver it, and digital programs are making it more accessible.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If your RA is controlled but your pain is not, you can join the waitlist.

What to do next

1. Keep treating the RA. Stay on the plan you and your rheumatologist agreed. Never stop or change disease-modifying medication without talking to them. New hot, swollen joints, fever, chest pain, breathlessness or eye pain need prompt medical attention.
2. Ask a direct question at your next visit. 'Does my pain match my disease activity?' If the answer is no, ask whether sensitization or a fibromyalgia-like overlay might be contributing.
3. Learn the difference between hurt and harm. Pain in a quiet joint is usually sensitivity, not new damage. Our guide to hurt versus harm explains why that matters.
4. Start practising. Gentle, regular movement, emotional expression and somatic tracking are low-risk and can begin today.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.